T80.A10D Non-ABO incompatibility with acute hemolytic transfusion reaction, subsequent encounter

Name of the Condition

• Non-ABO incompatibility with acute hemolytic transfusion reaction, subsequent encounter.

Summary

This condition describes an adverse reaction resulting from the transfusion of blood or blood products that is not due to ABO blood group incompatibility, specifically involving hemolysis, and is classified as a subsequent encounter. It occurs when the recipient’s immune system reacts to non-ABO antigens in the transfused material, leading to the destruction of red blood cells and associated clinical manifestations during a follow-up visit related to the initial reaction.

Causes

Non-ABO incompatibility with acute hemolytic transfusion reactions can arise from immune responses to minor blood group antigens, such as Rh, Kell, Duffy, or Kidd systems, or antibodies against platelet or plasma proteins. These reactions may be triggered by prior sensitization through pregnancy, previous transfusions, or organ transplants, where the recipient has developed antibodies against these antigens.

Risk Factors

• Prior exposure to incompatible blood products
• History of multiple transfusions or pregnancies
• Underlying immune-mediated conditions
• Use of blood products with non-ABO antigen mismatches
• Lack of pre-transfusion antibody screening in high-risk patients

Symptoms

• Fever, chills, or rigors
• Skin reactions (rash, urticaria, or flushing)
• Respiratory distress (wheezing, shortness of breath)
• Hypotension or tachycardia
• Hemolysis (evidenced by dark urine or jaundice)
• Renal impairment or oliguria

Diagnosis

Diagnosis involves correlating clinical symptoms with transfusion history, performing direct antiglobulin testing, antibody screening, or crossmatching to identify non-ABO antigen incompatibility. Documentation of the subsequent encounter and confirmation of the acute hemolytic reaction are essential for accurate coding.

Treatment Options

Treatment focuses on managing hemolysis, supporting renal function, and addressing symptoms. Interventions may include discontinuing the transfusion, administering fluids, using diuretics, and providing supportive care. In severe cases, additional measures such as dialysis or blood product management may be required.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and promptness of treatment. Most patients recover with appropriate management, but complications like renal failure or severe hemolysis can occur. Follow-up care includes monitoring for delayed reactions and ensuring resolution of symptoms.

Complications

• Acute kidney injury or renal failure
• Disseminated intravascular coagulation (DIC)
• Severe anemia requiring further transfusions
• Hypotensive shock
• Long-term organ damage

Lifestyle & Prevention

Prevention involves thorough pre-transfusion antibody screening, using compatible blood products, and verifying patient identity to avoid errors. Patients with a history of sensitization may require specialized blood matching. Educating healthcare providers on transfusion protocols can reduce risks.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as severe fever, respiratory distress, hypotension, or dark urine occur during or after a transfusion. Prompt evaluation is critical to prevent life-threatening complications.

Tips for Medical Coders

Document the subsequent encounter and confirm the acute hemolytic reaction to justify the use of T80.A10D. Ensure clinical notes specify the non-ABO incompatibility and the acute hemolytic nature of the reaction. Verify that the encounter is linked to the initial transfusion event for accurate coding.